The Veteran's claim for an evaluation higher than 30 percent for pulmonary sarcoidosis prior to April 1, 2016 was denied as the evidence did not show that he required daily high dose corticosteroids or immuno-suppressive medications.,The Veteran's claim for a compensable evaluation for bilateral sarcoidosis of the eye was denied as his vision correction was at least 20/40 in both eyes, without visual field defects.
The deciding factor: The evidence did not show that the Veteran required daily high dose corticosteroids or immuno-suppressive medications to manage his pulmonary sarcoidosis prior to April 1, 2016.,His vision correction was at least 20/40 in both eyes without visual field defects.
- Claimed conditions
- Pulmonary Sarcoidosis, Bilateral Sarcoidosis of the Eye
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- March 17, 2022
- Citation
- 22015439
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 22015439.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board found the reduction from 100 to 30 percent for pulmonary sarcoidosis was proper, but later determined this decision contained legal errors and revised it to restore the 100 percent rating.
- Remanded (sent back)
The Veteran's claims for extension of the temporary total evaluation and increased evaluations for his service-connected conditions are remanded due to incomplete adjudication and need for additional examinations.
- Granted
The Veteran's pulmonary sarcoidosis with decreased pulmonary function, granuloma, chronic fatigue, headaches, and joint pain is rated at a maximum of 100 percent. The Veteran's depressive disorder and PTSD are each rated at 70 percent. He is also granted TDIU based on his service-connected disabilities.
- Granted
The Veteran's service-connected pulmonary sarcoidosis, requiring continuous outpatient oxygen therapy and making him unable to work, qualifies for a TDIU rating from July 29, 2013.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.